Details for Patent: 10,988,436
Which drugs does patent 10,988,436 protect, and when does it expire?
Patent 10,988,436 protects CUVRIOR and is included in one NDA.
This patent has forty-eight patent family members in twenty-seven countries.
Summary for Patent: 10,988,436
| Title: | Crystalline form of triethylenetetramine tetrahydrochloride and its pharmaceutical use |
| Abstract: | The present invention describes a new crystalline form of triethylenetetramine tetrachloride which has improved room temperature stability over known forms and over the dichloride salt. The new crystalline form is characterised by having peaks in an XRPD spectrum at 22.9, 25.4, 25.8, 26.6, 34.6 and 35.3±0.1°2θ and Raman shifts 943, 1173, 1527 and 1612±5 cm−1. The crystalline form of triethylenetetramine tetrachloride is useful in the treatment of Wilson's disease. |
| Inventor(s): | Timothy James Morley, Ronnie Maxwell Lawrence, Naseem Amin |
| Assignee: | Gmp-Orphan SA , Orphalan SA |
| Application Number: | US16/917,266 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 10,988,436 |
|
Patent Claim Types: see list of patent claims | Composition; |
Drugs Protected by US Patent 10,988,436
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Orphalan | CUVRIOR | trientine tetrahydrochloride | TABLET;ORAL | 215760-001 | Apr 28, 2022 | RX | Yes | Yes | 10,988,436 | ⤷ Start Trial | Y | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 10,988,436
| Foriegn Application Priority Data | ||
| Foreign Country | Foreign Patent Number | Foreign Patent Date |
| 8290048 | May 4, 2018 | |
International Family Members for US Patent 10,988,436
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Argentina | 115080 | ⤷ Start Trial | |||
| Australia | 2019263969 | ⤷ Start Trial | |||
| Australia | 2024227767 | ⤷ Start Trial | |||
| Brazil | 112020018451 | ⤷ Start Trial | |||
| Canada | 3096423 | ⤷ Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
